Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice
暂无分享,去创建一个
R. Grantyn | M. Deliano | I. Melnick | M. Deliano | A. Dvorzhak | R. Grantyn | H. Stark | T. Rothe | D. Harnack | H. Stark | T. Rothe | A. M. Wójtowicz | A. Dvorzhak | D. Harnack | S. Paul | T. Vagner | I. Melnick | S. Paul | T. Vagner | A. Wójtowicz
[1] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[2] D. Sibley,et al. Striatal neurochemical changes in transgenic models of Huntington's disease , 2002, Journal of neuroscience research.
[3] P. Brown. Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[4] Jane S. Paulsen,et al. Huntington disease: natural history, biomarkers and prospects for therapeutics , 2014, Nature Reviews Neurology.
[5] A. Reiner,et al. Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons , 1991, Brain Research.
[6] Xin Jin,et al. Frontiers in Integrative Neuroscience Integrative Neuroscience , 2022 .
[7] Ann M. Graybiel,et al. Effects of Dopamine Depletion on Lfp Oscillations in Striatum Are Task-and Learning-dependent and Selectively Reversed by L-dopa Accessed Terms of Use Detailed Terms , 2022 .
[8] B. Walmsley,et al. Amplitude fluctuations in synaptic potentials evoked in cat spinal motoneurones at identified group Ia synapses. , 1983, The Journal of physiology.
[9] E. Abercrombie,et al. In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease , 2011, Front. Syst. Neurosci..
[10] D. Faber,et al. Tonic mGluR5/CB1‐dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin , 2013, The Journal of physiology.
[11] A. I. Shapovalov,et al. Relation between structural and release parameters at the frog sensory‐motor synapse. , 1984, The Journal of physiology.
[12] Carlos Cepeda,et al. Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease , 2003, The Journal of Neuroscience.
[13] Mei Kwan,et al. Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175 , 2012, PloS one.
[14] R. Palmiter,et al. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice , 2014, Neurobiology of Disease.
[15] M. Dragunow,et al. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease , 2000, Neuroscience.
[16] J. Bradshaw,et al. Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions , 2010, Brain Research Reviews.
[17] C. Cepeda,et al. Dopamine and Glutamate in Huntington's Disease: A Balancing Act , 2010, CNS neuroscience & therapeutics.
[18] T. Kita,et al. Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation , 1984, Brain Research.
[19] D. Housman,et al. Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice , 2012, Proceedings of the National Academy of Sciences.
[20] J. Penney,et al. Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical study , 2004, Journal of Chemical Neuroanatomy.
[21] Nicola Pavese,et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. , 2003, Brain : a journal of neurology.
[22] P. Greengard,et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Brundin,et al. Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice , 2002, Neurobiology of Disease.
[24] H. Scheich,et al. Learning a new behavioral strategy in the shuttle-box increases prefrontal dopamine , 2004, Neuroscience.
[25] Vishwanath T. Anekonda,et al. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. , 2012, Human molecular genetics.
[26] R. Albin,et al. Decreased striatal monoaminergic terminals in Huntington disease , 2000, Neurology.
[27] George V. Rebec,et al. Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington’s Disease , 2012, PloS one.
[28] H. Steinbusch,et al. Hyperdopaminergic Status in Experimental Huntington Disease , 2010, Journal of neuropathology and experimental neurology.
[29] Jack R Glaser,et al. Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease , 2012, PloS one.
[30] C. Colwell,et al. The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep , 2013, PloS one.
[31] Carlos Cepeda,et al. The corticostriatal pathway in Huntington's disease , 2007, Progress in Neurobiology.
[32] M. Schäfer,et al. Three Types of Tyrosine Hydroxylase-Positive CNS Neurons Distinguished by Dopa Decarboxylase and VMAT2 Co-Expression , 2006, Cellular and Molecular Neurobiology.
[33] Joshua L. Plotkin,et al. Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington’s Disease , 2014, Neuron.
[34] George V. Rebec,et al. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease , 2011, Front. Syst. Neurosci..
[35] G. Sedvall,et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. , 1997, Brain : a journal of neurology.
[36] M. Delong,et al. Milestones in research on the pathophysiology of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[37] A. Reiner,et al. Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice , 2013, Neurobiology of Disease.
[38] Gregor Thut,et al. Prediction of response speed by anticipatory high‐frequency (gamma band) oscillations in the human brain , 2005, Human brain mapping.
[39] Talia N. Lerner,et al. RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits , 2012, Neuron.
[40] Markus Siegel,et al. Corticostriatal Coordination through Coherent Phase-Amplitude Coupling , 2014, The Journal of Neuroscience.
[41] C. Cepeda,et al. Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines , 2010, PLoS currents.
[42] Martin Parent,et al. The role of dopamine in Huntington's disease. , 2014, Progress in brain research.
[43] Paul Greengard,et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors , 2010, Proceedings of the National Academy of Sciences.
[44] J. Penney,et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis , 1995, Neuroscience.
[45] R. Adalbert,et al. Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease , 2014, Neurobiology of Aging.
[46] Joshua L. Plotkin,et al. Synaptically driven state transitions in distal dendrites of striatal spiny neurons , 2011, Nature Neuroscience.
[47] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[48] C. Henneberger,et al. Brain-derived neurotrophic factor modulates GABAergic synaptic transmission by enhancing presynaptic glutamic acid decarboxylase 65 levels, promoting asynchronous release and reducing the number of activated postsynaptic receptors , 2005, Neuroscience.
[49] H. Yin,et al. Huntingtin Is Required for Normal Excitatory Synapse Development in Cortical and Striatal Circuits , 2014, The Journal of Neuroscience.
[50] F. Pierelli,et al. Abnormal spinal cord pain processing in Huntington’s disease. The role of the diffuse noxious inhibitory control , 2011, Clinical Neurophysiology.
[51] J. Brandt,et al. Predictors of neuropathological severity in 100 patients with Huntington's disease , 2003, Annals of neurology.
[52] A. Dvorzhak,et al. High Frequency Stimulation of the Subthalamic Nucleus Leads to Presynaptic GABA(B)-Dependent Depression of Subthalamo-Nigral Afferents , 2013, PloS one.
[53] A. Reiner,et al. Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease , 2014, Front. Syst. Neurosci..
[54] R. Wightman,et al. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease , 2006, Journal of neurochemistry.
[55] Weixing Shen,et al. Dopaminergic modulation of striatal networks in health and Parkinson's disease , 2014, Current Opinion in Neurobiology.
[56] S. Kirischuk,et al. N‐ethylmaleimide increases release probability at GABAergic synapses in layer I of the mouse visual cortex , 2006, The European journal of neuroscience.
[57] Carlos Cepeda,et al. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease. , 2015, Journal of neurophysiology.
[58] C. Wilson,et al. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[59] Vladimir Litvak,et al. Beta Reactivity, Prospective Facilitation of Executive Processing, and Its Dependence on Dopaminergic Therapy in Parkinson's Disease , 2012, The Journal of Neuroscience.
[60] Carlos Cepeda,et al. Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease , 2009, The Journal of Neuroscience.
[61] A. Parent,et al. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea. , 2011, Parkinsonism & related disorders.
[62] K. Murphy,et al. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels , 2015, Neurodegenerative Diseases.
[63] Charles J. Wilson,et al. Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons , 2008, Brain Research Reviews.
[64] Bernardo L Sabatini,et al. Phosphorylation of Ser1166 on GluN2B by PKA Is Critical to Synaptic NMDA Receptor Function and Ca2+ Signaling in Spines , 2014, The Journal of Neuroscience.
[65] Joshua L. Plotkin,et al. Corticostriatal synaptic adaptations in Huntington’s disease , 2015, Current Opinion in Neurobiology.
[66] G. Rebec,et al. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. , 2012, Basal ganglia.
[67] G. Turrigiano. The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses , 2008, Cell.
[68] S. W. Davies,et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[70] D. Surmeier,et al. Neurochemical characterization of the striatum and the nucleus accumbens in L-type Cav1.3 channels knockout mice , 2012, Neurochemistry International.
[71] D. James Surmeier,et al. Corticostriatal and Thalamostriatal Synapses Have Distinctive Properties , 2008, The Journal of Neuroscience.
[72] A. Reiner,et al. Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia , 2013, Movement disorders : official journal of the Movement Disorder Society.
[73] F. Walker. Huntington's disease , 2007, The Lancet.